Compare CMPX & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | CFFN |
|---|---|---|
| Founded | 2014 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 981.1M |
| IPO Year | 2020 | 2010 |
| Metric | CMPX | CFFN |
|---|---|---|
| Price | $1.91 | $7.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $14.57 | $7.25 |
| AVG Volume (30 Days) | ★ 10.8M | 852.0K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.51% |
| EPS Growth | N/A | ★ 79.31 |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $16,300,000.00 |
| Revenue This Year | N/A | $20.16 |
| Revenue Next Year | $934.41 | $6.62 |
| P/E Ratio | ★ N/A | $48.53 |
| Revenue Growth | N/A | ★ 6.54 |
| 52 Week Low | $1.61 | $5.51 |
| 52 Week High | $6.88 | $7.97 |
| Indicator | CMPX | CFFN |
|---|---|---|
| Relative Strength Index (RSI) | 24.24 | 59.97 |
| Support Level | $1.61 | $7.46 |
| Resistance Level | $3.63 | $7.84 |
| Average True Range (ATR) | 0.38 | 0.19 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 5.04 | 70.21 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.